SCHEMBL26847309

SCHEMBL26847309

C=C1NC(c2cccc(CSc3[nH]c(=O)cc(Cc4cccs4)c3C#N)c2)=NO1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACMSD Q8TDX5 13/20 0.39
▸ CYP2C19 P33261 1/20 0.38
▸ MEN1 O00255 4/20 0.33
▸ POLB P06746 4/20 0.33
▸ KMT2A Q03164 4/20 0.33
▸ KDM4E B2RXH2 1/20 0.33
▸ TSHR P16473 1/20 0.33
▸ GFER P55789 1/20 0.33
▸ HSD11B1 P28845 1/20 0.32
▸ TNF P01375 1/20 0.32
▸ NOD2 Q9HC29 1/20 0.32
▸ NOD1 Q9Y239 1/20 0.32
▸ ADORA2A P29274 1/20 0.31
▸ ADORA2B P29275 1/20 0.31
▸ ADORA1 P30542 1/20 0.31
▸ USP2 O75604 1/20 0.31
▸ PRNP P04156 1/20 0.31
▸ PKM P14618 1/20 0.31
▸ BLM P54132 1/20 0.31
▸ NPSR1 Q6W5P4 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26847313 0.91 ACMSD (0.32) ACMSDCYP2C19MEN1POLBKMT2A
SCHEMBL26847307 0.89 KMT2A (0.39) ACMSDMEN1POLBKMT2AKDM4E
SCHEMBL26847363 0.87 ACMSD (0.45) ACMSDCYP2C19MEN1POLBKMT2A
SCHEMBL26847367 0.83 KMT2A (0.40) ACMSDMEN1POLBKMT2AKDM4E
SCHEMBL24088104 0.81 ACMSD (0.59) ACMSDCYP2C19MEN1POLBKMT2A
SCHEMBL26847371 0.77 KDM4E (0.39) ACMSDCYP2C19MEN1POLBKMT2A
SCHEMBL17548432 0.76 ACMSD (0.68) ACMSDCYP2C19MEN1POLBKMT2A
SCHEMBL26847368 0.74 HSD11B1 (0.36) ACMSDCYP2C19MEN1POLBKMT2A
SCHEMBL24087879 0.74 ALDH1A1 (0.35) ACMSDMEN1POLBKMT2AKDM4E
SCHEMBL26847293 0.74 KDM4E (0.37) ACMSDMEN1POLBKMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE TES PHARMA S.R.L. (IT) 2023-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230381177-A1 INHIBITORS OF ALPHA-AMINO-BETA-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE ACMSD, GLS, ALDH7A1 ACMSD 1/4885CYP2C19 1550/4885MEN1 2572/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback